20/20 Biolabs, Inc. - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
AIDX Nasdaq 8071 2020biolabs.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for 20/20 Biolabs, Inc.

20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026 - Oct 2nd, 2026 6:31 am
20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model - Sep 29th, 2026 6:31 am
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch - Sep 5th, 2026 8:14 pm
Healwell AI (TSX:AIDX) Stock Draws Fresh Price Target Split After Quarterly Results - Sep 5th, 2026 11:06 am
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity - Aug 28th, 2026 4:26 pm
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity - Aug 26th, 2026 6:31 am
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level - Aug 17th, 2026 6:31 am
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour - Jul 30th, 2026 6:31 am
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy - Jul 27th, 2026 2:30 pm
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock - Jul 23rd, 2026 6:31 am
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth - Jul 9th, 2026 2:01 pm
Healwell AI (TSX:AIDX) Stock Fair Value Falls As Analysts Trim Growth Assumptions - Jun 26th, 2026 5:07 pm
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month - Jun 22nd, 2026 2:45 pm
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters - May 27th, 2026 6:31 am
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand - May 22nd, 2026 6:31 am
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress - May 20th, 2026 2:05 pm
Sidoti Events, LLC's May Micro-Cap Virtual Conference - May 20th, 2026 5:30 am
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026 - May 14th, 2026 6:31 am
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference - Apr 13th, 2026 5:00 am